Linda M Richardson Intercept Pharmaceuticals, Inc. (ICPT) insider trading activity

Linda M Richardson is EVP & Chief Commercial Officer of INTERCEPT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ICPT, which is worth approximately $0. The most recent transaction as insider was on Nov 08, 2023, when has been sold 26,585 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $505,115. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Linda M Richardson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 08 2023	SELL Sale (or disposition) back to the issuer	$505,115 $19.0 p/Share	26,585 Reduced 100.0%	0 Common Stock
Nov 08 2023	SELL Disposition due to a tender of shares in a change of control transaction	$317,414 $19.0 p/Share	16,706 Reduced 100.0%	0 Common Stock
Feb 14 2023	SELL Payment of exercise price or tax liability	$8,187 $21.21 p/Share	386 Reduced 0.88%	43,291 Common Stock
Jan 27 2023	BUY Grant, award, or other acquisition	-	12,200 Added 21.83%	43,677 Common Stock
Dec 31 2022	SELL Payment of exercise price or tax liability	$19,792 $12.37 p/Share	1,600 Reduced 4.84%	31,477 Common Stock
Sep 01 2022	SELL Payment of exercise price or tax liability	$10,782 $18.06 p/Share	597 Reduced 1.77%	33,077 Common Stock
Aug 15 2022	SELL Payment of exercise price or tax liability	$2,256 $18.19 p/Share	124 Reduced 0.37%	33,674 Common Stock
May 15 2022	SELL Payment of exercise price or tax liability	$2,217 $17.88 p/Share	124 Reduced 0.37%	33,798 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$2,724 $15.93 p/Share	171 Reduced 0.5%	33,922 Common Stock
Feb 14 2022	SELL Payment of exercise price or tax liability	$7,856 $14.85 p/Share	529 Reduced 1.53%	34,093 Common Stock
Jan 27 2022	BUY Grant, award, or other acquisition	-	10,300 Added 22.93%	34,622 Common Stock
Dec 31 2021	SELL Payment of exercise price or tax liability	$19,727 $16.29 p/Share	1,211 Reduced 4.74%	24,322 Common Stock
Nov 15 2021	SELL Payment of exercise price or tax liability	$3,022 $17.67 p/Share	171 Reduced 0.67%	25,533 Common Stock
Sep 01 2021	SELL Payment of exercise price or tax liability	$12,341 $15.05 p/Share	820 Reduced 3.09%	25,704 Common Stock
Aug 15 2021	SELL Payment of exercise price or tax liability	$2,551 $14.92 p/Share	171 Reduced 0.64%	26,524 Common Stock
May 15 2021	SELL Payment of exercise price or tax liability	$3,104 $18.15 p/Share	171 Reduced 0.64%	26,695 Common Stock
Feb 15 2021	BUY Grant, award, or other acquisition	-	5,531 Added 17.07%	26,866 Common Stock

LMR

Linda M Richardson

EVP & Chief Commercial Officer

Morristown, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ICPT shares.

Notify only if

Value

Insider Trading

Get notified when an Intercept Pharmaceuticals, Inc. insider buys or sells ICPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to INTERCEPT PHARMACEUTICALS, INC.

Account